China Universal Asset Management Company’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,676
Closed -$50.3K 526
2024
Q3
$50.3K Buy
13,676
+5,333
+64% +$19.6K 0.01% 386
2024
Q2
$34.1K Sell
8,343
-5,291
-39% -$21.6K ﹤0.01% 377
2024
Q1
$215K Buy
13,634
+5,446
+67% +$85.8K 0.03% 280
2023
Q4
$124K Buy
8,188
+6,379
+353% +$96.6K 0.02% 254
2023
Q3
$36.3K Buy
1,809
+1,030
+132% +$20.7K 0.01% 251
2023
Q2
$22K Buy
779
+6
+0.8% +$169 0.01% 257
2023
Q1
$13.3K Buy
773
+194
+34% +$3.34K ﹤0.01% 260
2022
Q4
$11.7K Buy
579
+45
+8% +$906 ﹤0.01% 213
2022
Q3
$12K Buy
+534
New +$12K 0.01% 189